Delivery Order SPE2DR25D1100-SPE2DR26FDC0D
Award Date 1/27/26
Potential Completion Date 1/28/26
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,196.54 by the Defense Logistics Agency on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,317.04 by the Defense Logistics Agency (DLA) on January 23, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pharmaceutical product. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by January 26, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,386.24 on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency (DLA) and will be completed by January 22, 2026, with performance taking place at the contractor's Conshohocken facility. The award represents a task order under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injectors, valued at $5,758.55. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 26, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $33,760.01 by the Defense Logistics Agency on January 27, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The delivery order, which carries an ultimate completion date of January 28, 2026, represents a non-competitive award issued without set-aside designation. Performance will be executed from the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,760.26 on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitive award was made by the Defense Logistics Agency, a subordinate agency of the Department of Defense responsible for supplying medical and pharmaceutical products to military healthcare systems. The contract utilizes firm fixed pricing and is...
- Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was awarded a delivery order valued at $12,175.92 on January 12, 2026, by the Defense Logistics Agency for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by January 13, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,087.67 for Repatha 140 mg/ml SureClick auto-injectors on September 25, 2025. This non-compete delivery order, which carries a firm fixed price structure and an ultimate completion date of September 26, 2025, was issued through the Medical Supply Chain, a defense-focused component of federal medical procurement. The contract represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 26, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order has a ceiling value of $3,750.79 and an ultimate completion date of November 28, 2025. The contract is not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...